Dow Jones

38 886,17

0,20%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Pivotal Therapeutics Inc (CE) (PVTTF)
Pivotal Therapeutics Inc (CE) (PVTTF) Actualités

PVTTF

Pivotal Therapeutics (CE) (PVTTF)

Pivotal Therapeutics Inc (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:PVTTF

Date	Heure	Source	Titre	Symbole	Société
05/05/2014	23h22	Marketwired	Crossover Healthcare Fund Announces Ownership Interest in Pivotal Therapeutics Inc.	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
07/10/2013	22h39	OTC Markets	Pivotal Therapeutics receives CDN $1.65 million in debt financing; Company closes equity portion of financing; over CDN $4.3 ...	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
02/10/2013	14h54	OTC Markets	Pivotal Therapeutics to close equity portion of financing; Enters into $5,000,000 debt financing agreement	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
13/09/2013	19h49	OTC Markets	Management Discussion and Analysis	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
13/09/2013	19h46	OTC Markets	Interim Financial Report	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
05/09/2013	18h45	OTC Markets	PIVOTAL THERAPEUTICS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS AND CORPORATE UPDATE	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
30/08/2013	21h24	OTC Markets	Supplemental Information	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
30/08/2013	21h11	OTC Markets	Quarterly Report	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
31/05/2013	06h44	OTC Markets	Annual Report	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
31/05/2013	06h33	OTC Markets	Proxy Materials	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
29/05/2013	18h34	OTC Markets	Pivotal Therapeutics Announces First Quarter 2013 Financial Results	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
07/05/2013	16h55	OTC Markets	Pivotal Therapeutics VASCAZEN®-REVEAL trial meets primary and secondary endpoints - VASCAZEN® shows 121% correction o...	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
02/05/2013	18h07	OTC Markets	Pivotal's Founder and Chairman Dr. George Jackowski receives Queen Elizabeth II Diamond Jubilee Medal	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
01/05/2013	00h08	OTC Markets	Pivotal Therapeutics VASCAZEN® - REVEAL Trial Top Line Results to be presented at American Heart Association's Arterioscl...	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
30/04/2013	02h38	OTC Markets	Pivotal Therapeutics Announces 2012 Financial Results	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
16/04/2013	21h00	Zacks	Pivotal Progresses with Vascazen - Analyst Blog	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
09/04/2013	14h45	OTC Markets	Pivotal Therapeutics VASCAZEN® - Meets Primary Endpoint in Reveal Trial - Top Line Results Accepted for Presentation at t...	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
06/03/2013	18h42	OTC Markets	Pivotal Therapeutics Exhibiting at the American College of Cardiology's 62nd Annual Scientific Session and EXPO	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
30/11/2012	00h12	OTC Markets	Home Country News Release	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)
28/05/2012	22h31	GlobeNewswire Inc.	Pivotal Therapeutics Reports 1st Quarter 2012 Results	USOTC:PVTTF	Pivotal Therapeutics Inc (CE)